NPPA's cap would cut a ₹270 cancer drug to ₹143
What a patient pays for a cancer drug its maker sells at ₹100, today and with NPPA's cap. The maker's ₹100 stays; the supply chain's share shrinks.
NPPA's cap would cut a ₹270 cancer drug to ₹143
What a patient pays for a cancer drug its maker sells at ₹100, today and with NPPA's cap. The maker's ₹100 stays; the supply chain's share shrinks.
₹ A PATIENT PAYS FOR A DRUG ITS MAKER SELLS AT ₹100
Maker's priceTrade margin
Trade margin: what distributors, chemists and hospital pharmacies add to the maker's price. The example assumes the 170% average mark-up is counted from the maker's price. NPPA expects MRPs to fall 20% to 70%, depending on each drug's mark-up today.
NPPA, minutes of the 151st Authority meeting, 8 October 2026; worked example · Oct 2026
Share it
The numbers
Embed it on your site
The code carries a credit line that links back to this page. Keep it with the chart.
From the insight
NPPA's cancer drug margin cap could save ₹2,500 crore a year